SCHEMBL30286426

SCHEMBL30286426

CC1(C)OC(c2ccc3[nH]ncc3c2)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 4/20 0.45
▸ ROCK2 O75116 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ ROCK1 Q13464 2/20 0.45
▸ METAP2 P50579 1/20 0.45
▸ CSNK2A1 P68400 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ MET P08581 2/20 0.44
▸ POLB P06746 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ SLC6A2 P23975 2/20 0.42
▸ SLC6A4 P31645 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29042384 0.74 AHR (0.42) MAPTGAARAB9ASLC6A2SLC6A4
SCHEMBL4833473 0.71 ROCK2 (0.52) NOS1ROCK2MAPTROCK1METAP2
SCHEMBL16655618 0.71 ALDH1A1 (0.38) MAPTKDM4EMEN1ALDH1A1GAA
SCHEMBL17863581 0.69 MAPK1 (0.37) MEN1RAB9AKMT2A
SCHEMBL29042371 0.68 MEN1 (0.42) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL12838085 0.67 ROCK2 (0.55) NOS1ROCK2MAPTROCK1METAP2
SCHEMBL30886948 0.67 SLC6A2 (0.41) NOS1ROCK2MAPTROCK1METAP2
SCHEMBL1583361 0.67 MET (0.80) NOS1ROCK2MAPTROCK1METAP2
SCHEMBL9917339 0.67 SLC6A2 (0.55) NOS1ROCK2ROCK1METAP2CSNK2A1
SCHEMBL15554029 0.67 TLR9 (0.50) NOS1ROCK2MAPTROCK1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115873007-A Condensed tetracyclic derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-03-31 — — CN disclosed
Send feedback